Clinical Trial Update: Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating radiotherapy dose supplementation for hypoxic lesions in patients with Stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Stage III Non-small-cell Lung Cancer | Phase 2 | Status: UNKNOWN